Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832702 | 12583270 | 2 | F | 2013 | 20160809 | 20160722 | 20160815 | EXP | US-GLAXOSMITHKLINE-US2016GSK103472 | GLAXOSMITHKLINE | 0.00 | F | Y | 81.65000 | KG | 20160815 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125832702 | 12583270 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | N | 18644 | |||||||||||
| 125832702 | 12583270 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | 100 MG, QD | N | 0 | 100 | MG | QD | |||||||
| 125832702 | 12583270 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 125832702 | 12583270 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | QD | |||||||
| 125832702 | 12583270 | 5 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 125832702 | 12583270 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, QD | 0 | 50 | MG | QD | ||||||||
| 125832702 | 12583270 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125832702 | 12583270 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 125832702 | 12583270 | 9 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 125832702 | 12583270 | 10 | C | BONIVA | IBANDRONATE SODIUM | 1 | UNK, Z | 0 | |||||||||||
| 125832702 | 12583270 | 11 | C | CALCIUM | CALCIUM | 1 | 500 MG, UNK | U | 0 | 500 | MG | ||||||||
| 125832702 | 12583270 | 12 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 1000 IU, UNK | U | 0 | 1000 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125832702 | 12583270 | 1 | Depression |
| 125832702 | 12583270 | 2 | Depression |
| 125832702 | 12583270 | 3 | Depression |
| 125832702 | 12583270 | 6 | Hypertension |
| 125832702 | 12583270 | 7 | Tachycardia |
| 125832702 | 12583270 | 8 | Hypertension |
| 125832702 | 12583270 | 9 | Sleep disorder |
| 125832702 | 12583270 | 10 | Osteopenia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125832702 | 12583270 | Crying | |
| 125832702 | 12583270 | Depressed mood | |
| 125832702 | 12583270 | Depression | |
| 125832702 | 12583270 | Drug ineffective | |
| 125832702 | 12583270 | Dry mouth | |
| 125832702 | 12583270 | Dysgeusia | |
| 125832702 | 12583270 | Emotional distress | |
| 125832702 | 12583270 | Flat affect |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125832702 | 12583270 | 3 | 2013 | 0 | ||
| 125832702 | 12583270 | 4 | 201606 | 0 | ||
| 125832702 | 12583270 | 5 | 2013 | 0 |